These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23490149)

  • 41. Monophosphoryl lipid A inhibits the cytokine response of endothelial cells challenged with LPS.
    Stark R; Choi H; Koch S; Lamb F; Sherwood E
    Innate Immun; 2015 Aug; 21(6):565-74. PubMed ID: 25540284
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
    Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glycyrrhizin and isoliquiritigenin suppress the LPS sensor toll-like receptor 4/MD-2 complex signaling in a different manner.
    Honda H; Nagai Y; Matsunaga T; Saitoh S; Akashi-Takamura S; Hayashi H; Fujii I; Miyake K; Muraguchi A; Takatsu K
    J Leukoc Biol; 2012 Jun; 91(6):967-76. PubMed ID: 22422925
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunology. The shape of things to come.
    Fitzgerald KA; Golenbock DT
    Science; 2007 Jun; 316(5831):1574-6. PubMed ID: 17569850
    [No Abstract]   [Full Text] [Related]  

  • 45. Lipid A-Mediated Bacterial-Host Chemical Ecology: Synthetic Research of Bacterial Lipid As and Their Development as Adjuvants.
    Shimoyama A; Fukase K
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684874
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structure-Based Design and Synthesis of Lipid A Derivatives to Modulate Cytokine Responses.
    Verpalen ECJM; Brouwer AJ; Wolfert MA; Boons GJ
    Chemistry; 2024 Jun; 30(32):e202400429. PubMed ID: 38587187
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.
    Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK
    Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carboxylic and O-acetyl moieties are essential for the immunostimulatory activity of glucuronoxylomannan: a novel TLR4 specific immunostimulator from Auricularia auricula-judae.
    Perera N; Yang FL; Chern J; Chiu HW; Hsieh CY; Li LH; Zhang YL; Hua KF; Wu SH
    Chem Commun (Camb); 2018 Jun; 54(51):6995-6998. PubMed ID: 29799035
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TLR4-Based Immunotherapeutics in Cancer: A Review of the Achievements and Shortcomings.
    Shetab Boushehri MA; Lamprecht A
    Mol Pharm; 2018 Nov; 15(11):4777-4800. PubMed ID: 30226786
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis of a monophosphoryl derivative of Escherichia coli lipid A and its efficient coupling to a tumor-associated carbohydrate antigen.
    Tang S; Wang Q; Guo Z
    Chemistry; 2010 Jan; 16(4):1319-25. PubMed ID: 19943286
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diamino Allose Phosphates: Novel, Potent, and Highly Stable Toll-like Receptor 4 Agonists.
    Khalaf JK; Bess LS; Walsh LM; Ward JM; Johnson CL; Livesay MT; Jackson KJ; Evans JT; Ryter KT; Bazin-Lee HG
    J Med Chem; 2023 Oct; 66(20):13900-13917. PubMed ID: 37847244
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lipid A, the immunostimulatory principle of lipopolysaccharides?
    Loppnow H; Dürrbaum I; Brade H; Dinarello CA; Kusumoto S; Rietschel ET; Flad HD
    Adv Exp Med Biol; 1990; 256():561-6. PubMed ID: 2327301
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantum dots decorated with pathogen associated molecular patterns as fluorescent synthetic pathogen models.
    Barr TA; Krembuszewski M; Gupta M; Gray D; Mareque-Rivas JC
    Mol Biosyst; 2010 Sep; 6(9):1572-5. PubMed ID: 20407668
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lipid A structural modifications in extreme conditions and identification of unique modifying enzymes to define the Toll-like receptor 4 structure-activity relationship.
    Scott AJ; Oyler BL; Goodlett DR; Ernst RK
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Nov; 1862(11):1439-1450. PubMed ID: 28108356
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kdo2 -lipid A: structural diversity and impact on immunopharmacology.
    Wang X; Quinn PJ; Yan A
    Biol Rev Camb Philos Soc; 2015 May; 90(2):408-27. PubMed ID: 24838025
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lipopolysaccharide lipid A: A promising molecule for new immunity-based therapies and antibiotics.
    Garcia-Vello P; Di Lorenzo F; Zucchetta D; Zamyatina A; De Castro C; Molinaro A
    Pharmacol Ther; 2022 Feb; 230():107970. PubMed ID: 34454000
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recognition of LPS by TLR4: potential for anti-inflammatory therapies.
    Nijland R; Hofland T; van Strijp JA
    Mar Drugs; 2014 Jul; 12(7):4260-73. PubMed ID: 25056632
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Progress in the synthesis and biological evaluation of lipid A and its derivatives.
    Gao J; Guo Z
    Med Res Rev; 2018 Mar; 38(2):556-601. PubMed ID: 28621828
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunobiology and application of toll-like receptor 4 agonists to augment host resistance to infection.
    Hernandez A; Patil NK; Stothers CL; Luan L; McBride MA; Owen AM; Burelbach KR; Williams DL; Sherwood ER; Bohannon JK
    Pharmacol Res; 2019 Dec; 150():104502. PubMed ID: 31689522
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis of ceramidated GLA-60 derivatives.
    Nakamura T; Shiozaki M; Kurakata S
    Carbohydr Res; 2002 Sep; 337(15):1343-9. PubMed ID: 12204617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.